Medical Equipment

Global Digital Neuro Biomarkers Market Analysis 2026–2030 with Strategic Forecast Insights

April 8, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Digital Neuro Biomarkers Market By 2030 Starting From Its 2026 Size?

The size of the digital neuro biomarkers market has expanded considerably in recent years. It is projected to increase from $0.95 billion in 2025 to $1.22 billion in 2026, exhibiting a compound annual growth rate (CAGR) of 27.5%. The expansion witnessed during the historical period can be attributed to the rising prevalence of neurological disorders, the increasing adoption of wearable devices, a growing focus on cognitive assessment, advancements in neuroimaging technologies, and early research efforts in digital biomarker development.

The digital neuro biomarkers market is anticipated to experience rapid expansion in the coming years. By 2030, it is projected to attain a valuation of $3.19 billion, progressing at a compound annual growth rate (CAGR) of 27.2%. Factors contributing to this growth over the forecast period include the expanding incorporation of artificial intelligence in neurological diagnosis, the rising need for remote patient observation, the broadening of tele-neurology offerings, increasing capital allocation into neuroscience investigations, and the creation of tailored neurology treatment approaches. Key trends anticipated during this period encompass augmented utilization of cloud-based neurological data analysis, the uptake of real-time brain surveillance technologies, the proliferation of mobile cognitive evaluation tools, the incorporation of machine learning into biomarker scrutiny, and the advancement of predictive and precision neurology platforms.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=30571&type=smp

Which Growth Drivers Are Contributing To The Progress Of The Digital Neuro Biomarkers Market?

An escalating emphasis on the prompt identification and continuous observation of neurological conditions is anticipated to fuel the expansion of the digital neuro biomarkers market. Such early detection and monitoring utilize digital tools, including wearable technology, mobile software, and sensor devices, for ongoing evaluation of neurological function, cognitive abilities, and behavior, thereby facilitating the swift recognition of these conditions. This heightened attention is largely due to ongoing public health campaigns and clinical objectives designed to pinpoint cognitive decline and neurodegenerative ailments prior to the onset of advanced symptoms. Digital neuro biomarkers play a crucial role in these endeavors by furnishing unbiased, instantaneous data, which assists medical professionals and researchers in identifying nuanced neurological alterations and implementing early therapeutic strategies. A relevant example is from 2024, where the U.S. Centres for Disease Control and Prevention’s Healthy Brain Initiative reported that approximately one billion individuals worldwide are impacted by neurological disorders, with around 50 million suffering from epilepsy and 24 million from Alzheimer’s disease. Consequently, the concentrated effort on the early discovery and ongoing surveillance of neurological disorders using digital solutions is a key driver for the expansion of the digital neuro biomarkers market.

Which Segment Categories Define The Digital Neuro Biomarkers Market?

The digital neuro biomarkers market covered in this report is segmented –

1) By Type: Wearable, Mobile-Based Applications, Sensors, Other Types

2) By Deployment Mode: Cloud-Based Platforms, On-Premise Platforms, Hybrid Deployment Models

3) By Biomarker Type: Cognitive Digital Biomarkers, Motor Function Digital Biomarkers, Speech And Language Digital Biomarkers, Behavioral Digital Biomarkers

4) By End-User: Healthcare Companies, Healthcare Providers, Payers, Other End-Users

Subsegments:

1) By Wearable: Smart Wristbands, Smart Headbands, Smart Watches, Smart Clothing, Implantable Devices

2) By Mobile-Based Applications: Cognitive Assessment Applications, Neurological Monitoring Applications, Mental Health Tracking Applications, Motor Function Assessment Applications, Speech And Language Tracking Applications

3) By Sensors: Electroencephalography Sensors, Electrocardiography Sensors, Eye Tracking Sensors, Motion Tracking Sensors, Biometric Monitoring Sensors

4) By Other Types: Cloud Based Platforms, Data Analytics Tools, Digital Therapeutic Platforms, Artificial Intelligence Enabled Assessment Tools, Virtual Reality Based Assessment Tools

What Major Market Trends Are Driving Changes In The Digital Neuro Biomarkers Market?

Major companies operating in the digital neuro biomarkers market are concentrating on developing open-access research infrastructure, such as WearGait PD. This effort is aimed at facilitating the development, validation, and regulatory assessment of wearable-based digital neuro biomarkers for various neurological disorders. WearGait PD functions as a regulatory science dataset, providing synchronized data from wearable sensors and gait patterns from individuals diagnosed with Parkinson’s disease and age-matched controls. This enables the extraction and evaluation of gait-derived digital biomarkers for effective disease monitoring and progression assessment. For example, in July 2024, the U.S. Food and Drug Administration (FDA), a U.S.-based regulatory agency, released WearGait PD: Wearables Dataset for Gait in Parkinson’s Disease and Age-Matched Controls. This open-access dataset is specifically intended to assist researchers and industry developers in deriving and validating digital biomarkers. The dataset contains raw inertial measurement unit (IMU) acceleration and rotational velocity data, insole pressure recordings, and synchronized gait annotations, thereby simplifying algorithm testing, metric validation, and the creation of wearable sensor-based monitoring tools.

Which Companies Are Leading Innovation In The Digital Neuro Biomarkers Market?

Major companies operating in the digital neuro biomarkers market are F. Hoffmann-La Roche AG, Merck KGaA, Biogen Inc., Evidation Health Inc., Huma Therapeutics Limited, Altoida Inc, Cogstate Limited, Quibim S.L., Empatica Inc., Linus Health Inc., Cambridge Cognition Holdings plc, Brainomix Limited, Mindstrong Health Inc., Neurotrack Technologies Inc., Feel Therapeutics Inc., BrainCheck Inc., IXICO plc, NeuraMetrix Inc., NeuraLight Ltd., Koneksa Health Inc., Sonde Health Inc., Aural Analytics Inc., Winterlight Labs Inc.

Read the full digital neuro biomarkers market report here:

https://www.thebusinessresearchcompany.com/report/digital-neuro-biomarkers-market-report

Which Region Currently Holds The Largest Share Of The Digital Neuro Biomarkers Market?

North America was the largest region in the digital neuro biomarkers market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the digital neuro biomarkers market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Digital Neuro Biomarkers Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=30571&type=smp

Browse Through More Reports Similar to the Global Digital Neuro Biomarkers Market 2026, By The Business Research Company

Neurological Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/neurological-biomarkers-global-market-report

Central Nervous System Biomarkers Market Report 2026

https://www.thebusinessresearchcompany.com/report/central-nervous-system-biomarkers-global-market-report

clinical biomarkers global market report

https://www.thebusinessresearchcompany.com/report/clinical-biomarkers-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795